It has also been used in Phase I clinical trials, where the radiolabeled peptide 68Ga-NOTA-WL12 uptake was strongly correlated with PD-L1-expressing non-small-cell lung cancer cells; it was also tolerated well by patients and cleared safely [46]. Here, CD274 is linked to non-small cell lung carcinoma.